HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meso-dihydroguaiaretic acid induces apoptosis and inhibits cell migration via p38 activation and EGFR/Src/intergrin β3 downregulation in breast cancer cells.

AbstractAIMS:
Meso-dihydroguaiaretic acid (MDA) is known for its anti-inflammatory, anti-oxidant, anti-bacterial, and anti-tumor activity. However, the anti-breast cancer effect and the mechanism of MDA remain undefined.
MAIN METHODS:
In this study, we examined the anti-cancer activity and the mechanisms of action of MDA in breast cancer cell lines, 4T-1 and MCF-7 cells; and 4T-1 bearing mouse model.
KEY FINDINGS:
MDA showed cytotoxic effects on 4T-1 and MCF-7 cells in a dose-dependent manner. Moreover, MDA increased the amount of Annexin V-positive apoptotic bodies, phosphorylated JNK and p38 in 4T-1 cells. MDA also down-regulated cell-cycle dependent proteins, CDK-4 and cyclin D1; and induced cleaved caspase-3 in MDA-treated 4T-1 cells. We further verified that MDA-induced apoptosis is mediated by p38 and caspase-3 activation in 4T-1 cells. Next, we studied the effect of MDA treatment on cell migration and found that MDA significantly reduced cell migration. Moreover, MDA reduced EGFR and intergrin β3 expression, and dephosphorylated Src in a dose-dependent manner in 4T-1 cells. Furthermore, we observed in vivo effect of MDA in 4T-1 cell inoculated mice. MDA (20mg/kg/day) significantly suppressed mammary tumor volume and activated caspase-3 in tumor tissues.
SIGNIFICANCE:
These results suggest novel targets of MDA in breast cancer in vitro and in vivo, making it a potential candidate as a chemotherapeutic drug.
AuthorsMin Sun Choi, Ha Jin Jeong, Tae-Hoon Kang, Heung-Mook Shin, Seung Tack Oh, Yura Choi, Songhee Jeon
JournalLife sciences (Life Sci) Vol. 141 Pg. 81-9 (Nov 15 2015) ISSN: 1879-0631 [Electronic] Netherlands
PMID26382595 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Integrin beta3
  • Lignans
  • dihydroguaiaretic acid
  • Guaiacol
  • ErbB Receptors
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Cell Survival (drug effects)
  • Dose-Response Relationship, Drug
  • Down-Regulation (drug effects)
  • Enzyme Activation (drug effects)
  • ErbB Receptors (biosynthesis, genetics)
  • Female
  • Genes, src (drug effects)
  • Guaiacol (analogs & derivatives, pharmacology)
  • Humans
  • Integrin beta3 (biosynthesis, genetics)
  • Lignans (pharmacology)
  • MCF-7 Cells
  • Mammary Neoplasms, Experimental (drug therapy)
  • Mice
  • p38 Mitogen-Activated Protein Kinases (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: